102 related articles for article (PubMed ID: 18413261)
1. Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathways.
Bromberg-White JL; Duesbery NS
Methods Enzymol; 2008; 438():355-65. PubMed ID: 18413261
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
[TBL] [Abstract][Full Text] [Related]
3. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS
Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of host signalling pathways by anthrax toxins.
Turk BE
Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
[TBL] [Abstract][Full Text] [Related]
5. Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.
Bromberg-White JL; Boguslawski E; Hekman D; Kort E; Duesbery NS
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8979-92. PubMed ID: 21989728
[TBL] [Abstract][Full Text] [Related]
6. Effects of anthrax lethal toxin on human primary keratinocytes.
Koçer SS; Matic M; Ingrassia M; Walker SG; Roemer E; Licul G; Simon SR
J Appl Microbiol; 2008 Dec; 105(6):1756-67. PubMed ID: 19120626
[TBL] [Abstract][Full Text] [Related]
7. Chemical genetic screening identifies critical pathways in anthrax lethal toxin-induced pathogenesis.
Panchal RG; Ruthel G; Brittingham KC; Lane D; Kenny TA; Gussio R; Lazo JS; Bavari S
Chem Biol; 2007 Mar; 14(3):245-55. PubMed ID: 17379140
[TBL] [Abstract][Full Text] [Related]
8. Role of mitogen-activated protein kinase kinase kinases in signal integration.
Cuevas BD; Abell AN; Johnson GL
Oncogene; 2007 May; 26(22):3159-71. PubMed ID: 17496913
[TBL] [Abstract][Full Text] [Related]
9. Novel repression of the glucocorticoid receptor by anthrax lethal toxin.
Webster JI; Moayeri M; Sternberg EM
Ann N Y Acad Sci; 2004 Jun; 1024():9-23. PubMed ID: 15265771
[TBL] [Abstract][Full Text] [Related]
10. Yersinia inhibits host signaling by acetylating MAPK kinases.
Bliska JB
ACS Chem Biol; 2006 Jul; 1(6):349-51. PubMed ID: 17163770
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.
Ha SD; Reid C; Meshkibaf S; Kim SO
J Biol Chem; 2016 Apr; 291(16):8745-55. PubMed ID: 26912657
[TBL] [Abstract][Full Text] [Related]
12. The effects of anthrax lethal factor on the macrophage proteome: potential activity on nitric oxide synthases.
Kim J; Park H; Myung-Hyun J; Han SH; Chung H; Lee JS; Park JS; Yoon MY
Arch Biochem Biophys; 2008 Apr; 472(1):58-64. PubMed ID: 18269913
[TBL] [Abstract][Full Text] [Related]
13. Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice.
Abi-Habib RJ; Singh R; Leppla SH; Greene JJ; Ding Y; Berghuis B; Duesbery NS; Frankel AE
Clin Cancer Res; 2006 Dec; 12(24):7437-43. PubMed ID: 17189417
[TBL] [Abstract][Full Text] [Related]
14. Interactions between mitogen-activated protein kinase and protein kinase C signaling during oocyte maturation and fertilization in a marine worm.
Stricker SA
Mol Reprod Dev; 2009 Aug; 76(8):708-21. PubMed ID: 19391097
[TBL] [Abstract][Full Text] [Related]
15. Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling.
Liu T; Milia E; Warburton RR; Hill NS; Gaestel M; Kayyali US
J Cell Physiol; 2012 Apr; 227(4):1438-45. PubMed ID: 21618534
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Substrate-selective Exosite within the Metalloproteinase Anthrax Lethal Factor.
Goldberg AB; Cho E; Miller CJ; Lou HJ; Turk BE
J Biol Chem; 2017 Jan; 292(3):814-825. PubMed ID: 27909054
[TBL] [Abstract][Full Text] [Related]
17. Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion.
Al-Dimassi S; Salloum G; Saykali B; Khoury O; Liu S; Leppla SH; Abi-Habib R; El-Sibai M
Int J Oncol; 2016 May; 48(5):1913-20. PubMed ID: 26984023
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.
Duesbery NS; Resau J; Webb CP; Koochekpour S; Koo HM; Leppla SH; Vande Woude GF
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4089-94. PubMed ID: 11259649
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase.
Koo HM; VanBrocklin M; McWilliams MJ; Leppla SH; Duesbery NS; Vande Woude GF
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3052-7. PubMed ID: 11867750
[TBL] [Abstract][Full Text] [Related]
20. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
